Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, EyePoint Pharmaceuticals Inc’s stock clocked out at $5.91, down -3.90% from its previous closing price of $6.15. In other words, the price has decreased by -$3.90 from its previous closing price. On the day, 0.71 million shares were traded.
Ratios:
To gain a deeper understanding of EYPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.45 and its Current Ratio is at 5.50. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on January 07, 2025, initiated with a Buy rating and assigned the stock a target price of $33.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.Jefferies initiated its Buy rating on August 28, 2024, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 23 ’24 when ANTHONY P. ADAMIS bought 67,100 shares for $10.04 per share.
David R. Guyer bought 36,975 shares of EYPT for $329,817 on Oct 14 ’24. On Aug 20 ’24, another insider, DICICCO WENDY F, who serves as the Director of the company, bought 2,567 shares for $7.79 each. As a result, the insider paid 19,997 and bolstered with 9,967 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 8.82 while its Price-to-Book (P/B) ratio in mrq is 1.45.
Stock Price History:
Over the past 52 weeks, EYPT has reached a high of $29.31, while it has fallen to a 52-week low of $5.90. The 50-Day Moving Average of the stock is -21.01%, while the 200-Day Moving Average is calculated to be -34.35%.
Shares Statistics:
A total of 68.25M shares are outstanding, with a floating share count of 59.20M. Insiders hold about 13.25% of the company’s shares, while institutions hold 97.18% stake in the company.
